| 08:00-08:50 |
Registration |
|
| 08:50-09:00 |
Opening remark |
김윤중 KMDS 회장 |
| 09:00-10:10 |
Plenary session I :
Autoimmune diseases in movement disorders |
좌장: 한림의대 김윤중 |
| 09:00-09:30 |
Immune-mediated movement disorders |
Chang Gung University,
Yih-Ru Wu(Taiwan) |
| 09:30-10:00 |
Immunotherapy for movement disorders |
서울의대 김한준 |
| 10:00-10:10 |
Q&A |
|
| 10:10-10:20 |
Break |
|
| 10:20-12:00 |
Plenary session II :
Inflammation and immunotherapy in Parkinson's disease |
좌장: 연세의대 손영호 |
| 10:20-11:00 |
Inflammation in pathogenesis of PD |
서울의대 이승재 |
| 11:00-11:50 |
Immunization treatment for PD targeting alpha-synuclein |
Uppsala University
Joakim Bergström(Sweden) |
| 11:50-12:00 |
Q&A |
|
| 12:00-13:00 |
Award/General Meeting |
진행: 김중석 총무이사 |
| Lunch |
|
| 13:00-14:00 |
Video round |
진행: 조진환 학술이사 |
| 14:00-14:30 |
Poster session |
좌장: 경북의대 이호원
연세의대 류철형 |
| 14:30-16:10 |
Parallel session I :
New landscape in Ataxia |
좌장: 가톨릭의대 이광수 |
Parallel session II :
Pathogenesis for Parkinson's disease |
좌장: 영남의대 박미영 |
| 14:30-15:00 |
Autosomal dominant ataxia in Asia |
을지의대 이웅우 |
Autophagy |
울산의대 장우영 |
| 15:00-15:30 |
Autosomal recessive ataxia in Asia |
Niigata University
Osamu Onodera(Japan) |
Mitochondrial pathology |
부산의대 이재혁 |
| 15:30-16:00 |
Genotype-Phenotype correlations: Insights from next generation sequencing |
성균관의대 김지선 |
Oxidative stress |
인제의대 이재정 |
| 16:00-16:10 |
Q&A |
|
| 16:10-16:30 |
Break |
|
| 16:30-18:10 |
Parallel session III :
Emerging treatments in movement disorders |
좌장: 한림의대 마효일 |
Parallel session IV : Role of neurologists in deep brain stimulation |
좌장: 고려의대 고성범 |
| 16:30-17:00 |
Gene editing and gene silencing therapy |
툴젠 이정민 |
Candidates selection :
indication vs. contraindication |
아주의대 윤정한 |
| 17:00-17:30 |
Tau-antibody in movement disorders |
서울의대 이지영 |
Pearls in setting stimulation parameters |
동아의대 천상명 |
| 17:30-18:00 |
Stem cell treatment in Parkinson's disease |
연세의대 이필휴 |
How to approach for trouble-shooting cases |
성균관의대 윤진영 |
| 18:00-18:10 |
Q&A |
|
Q&A |
|
| 18:10 |
Closing Remark |
|
